PURPOSE:

The continuous monitoring of outcomes peri/post Health Technology Assessments (HTAs) is a challenge for every stakeholder involved. Data quality as well as reliability depend strongly on patients and healthcare providers. However, technology reported outcomes (TechROs) relying on personal wearable sensors and collecting dense daily life datasets, could be a tool to change that. Thus, this session will discuss how TechROs could lead to simplification, standardization, scale and automatization peri/post HTAs. Ultimately, the question is how “pay for performance” agreements could benefit from TechROs.

SESSION DESCRIPTION:

Continuous accurate outcomes monitoring for HTAs is challenging. The increasing number of personal wearable sensors is about to relieve that burden, as it will allow for easier and more accurate collection of data. It would open doors for value-based health care and for improving the quantification of the broader value of new treatments and their cost-effectiveness analysis in general. Even “pay for performance” agreements could become feasible on a large scale.

This session will start with an introduction into the possibilities that TechROs could offer in general and then deep-dive into how value-based health care could benefit and what initiatives from regulators are under way (15 minutes, Saka). Then the focus will shift towards the current technological developments in the field of TechROs and where those will lead to. Here, the academic (15 minutes, Wac), as well as the commercial perspective (15 minutes, Saka) will be presented. Afterwards, the focus will shift towards pharmaceutical companies operating in this field and the potential business impact of TechRO opportunities (15 minutes, Özer Stillman). This session will finish with a 15-minute plenary discussion between the audience and the speakers (15 minutes). The session should benefit policy makers as well as industry representatives by introducing and aligning on the understanding of TechROs as an emerging technology.